Monday, November 9 at 16:00 GMT | 17:00 CET | 11:00 EST | 08:00 PST
Diagnosing and monitoring plasma cell disorders presents ongoing challenges for clinical laboratories. While serum protein electrophoresis (SPEP), immunofixation electrophoresis (IFE), and serum free light chain (sFLC) testing remain central to monoclonal protein assessment, issues such as therapeutic monoclonal antibody interference, antigen excess, and complex result interpretation can impact diagnostic confidence and patient management.
Join our expert speaker, Stephanie Brunelle, PhD, for an accredited webinar exploring the clinical utility of conventional monoclonal protein testing methods, the limitations that laboratorians encounter in routine practice, and the emerging role of mass spectrometry in monoclonal protein detection and characterization.
Attendees will gain a balanced perspective on current best practices, analytical pitfalls, and future directions in monoclonal protein testing that may improve diagnostic confidence and support optimal patient care.
Webinar details
- Cost: Free to attend
- Location: Online
- Duration: 60 minutes
- Format: Live discussion format
Can't attend live?
Register to receive access to the recording after the event, allowing you to catch up on the discussion and revisit key insights at your convenience.
Accreditation statement
SelectScience® is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.
Certificate of attendance
All attendees who join the live forum will automatically receive a certificate of attendance, including a summary of key learning outcomes, to support their continuing professional development.
If you watch the on-demand recording, a certificate of attendance can be requested by emailing editor@selectscience.net.
About CLINICAL24
CLINICAL24 is a global initiative dedicated to exploring the challenges facing modern clinical laboratories and highlighting the technologies, expertise, and collaborative approaches helping to improve patient care worldwide.
Who should attend?
Laboratory professionals, laboratory leaders and decision-makers, medical directors, primary care providers, hematologists, and oncologists with an interest in multiple myeloma and monoclonal gammopathy testing.
What will this webinar cover?
Accurate interpretation of monoclonal protein testing requires an understanding of both the strengths and limitations of current laboratory methodologies. This webinar will provide attendees with practical guidance on the clinical application of established testing approaches while exploring future developments in the field.
Topics include:
- The role of monoclonal protein testing in plasma cell disorders including multiple myeloma and related monoclonal gammopathies
- Best practices for SPEP, IFE, and sFLC testing, including how these assays complement one another in clinical workflows
- Analytical and interpretive challenges, including therapeutic monoclonal antibody interference, antigen excess, sample non-linearity, and variability in M-protein quantification
- Monoclonal versus polyclonal sFLC detection, and considerations for result interpretation
- Emerging MALDI-ToF mass spectrometry technologies and their potential advantages for monoclonal protein detection and characterization
- Future directions in monoclonal protein testing and the implications for laboratory practice and patient care
Presenters
Stephanie Brunelle, Ph.D.
Medical Science Liaison and Scientific Partnerships Manager,
Binding Site, part of Thermo Fisher Scientific
Stephanie Brunelle, Ph.D., is a Medical Science Liaison and Scientific Partnerships Manager at Binding Site, part of Thermo Fisher Scientific focusing on diagnostics for multiple myeloma and other monoclonal gammopathies. She brings more than a decade of experience across research, biotechnology, and product leadership, with expertise in cell and molecular biology, clinical diagnostics, and scientific partnerships.
Lucy Lawrence
Science Editor
SelectScience